Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
about
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer CellsThe evolution of endothelial regulatory paradigms in cancer biology and vascular repairSynergistic anti-inflammatory effects of nobiletin and sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cellsEpigallocatechin 3-gallate and green tea catechins: United they work, divided they failChemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.Anti-Inflammatory Agents for Cancer Therapy.Exploiting the critical perioperative period to improve long-term cancer outcomesCombination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.Statin use and cancer risk: a comprehensive reviewSalvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor.HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathwayFinding multiple target optimal intervention in disease-related molecular network.Reactive oxygen species in cancer.Alternative macrophage activation and metabolism.Cardiovascular medications in angiogenesis--how to avoid the sting in the tail.Perioperative statin therapy.Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.Synergistic drug combinations from electronic health records and gene expression.Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.A metabolite of nobiletin, 4'-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis.Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin.Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin.The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma.Response
P2860
Q26798203-9CAC06BE-42C7-4C35-AA53-C5B4AE3A4AB6Q26822678-A3AC40CB-46D8-4151-9146-0B0F6E90CD18Q28731439-BE55FB93-30B9-42D7-A2B8-3D14CEB913B1Q33655389-0287180F-052E-40AB-B00D-6A1580FD6151Q33716515-ECAB7C13-2A8A-4084-A5FC-8BC934951A08Q33744129-0BBF3C94-835D-4EC3-AE4E-138CD6597E13Q33871661-B0E2C98E-00C4-4FE1-88FC-76489ED67825Q33895607-D2BEDA11-CAE4-4387-8FDD-3FBA59FA88B3Q34004787-FA1A4D05-0E6E-4075-8AA4-97CD2EABE127Q34021312-578E3759-6327-436C-A58B-0164A0ABDA1CQ34442838-CCCE7201-C4E1-4246-95C3-1AE07E1409F7Q35885008-C1CD62AB-BDE8-4C03-A0C2-2C689F5200B6Q37073682-20125B86-A983-4541-9378-9C90AFC4D400Q37170511-E0D33D31-045E-4605-A685-EFA496BAF17FQ37431048-E65C3A5B-6258-4647-91D3-85CE18BD1C04Q37804862-4B9BCB32-8BD6-49A7-BC32-320474BA40CBQ38001305-11218DB3-C3B6-4BE5-9662-21247BE9C9D5Q38092149-8A494C64-6897-414D-BD95-4F66407A097FQ38097532-03D71895-8900-44A4-B93E-295F70A0B80BQ38328376-18721B37-11F7-4C67-A37C-0590BF7F45A9Q38716191-518853B5-94DC-4FDD-988F-D5E935BDF3FCQ39063066-1F7F750E-C040-455A-B485-FF77856822E2Q39111678-6F207B83-213D-4D84-8637-D9996AF175EDQ39227514-F7E78313-8664-479D-A3BE-4FE40161ACDAQ41080847-746BE0F2-6920-40E6-A07E-9160861B7DB6Q41589499-C5B2D2C8-F8E9-44D1-9C51-B4AA9A93BC81Q47612442-6A9305BD-6148-451A-A0B5-B767E722B987Q48513576-F809F5C8-6BF0-42FF-ACD9-ED6C847C52DCQ51427511-0D7D2E7C-9E61-403F-A746-CEC6119F1AA7Q52868660-591D7816-CEFD-4C88-B6F5-167F48582F3BQ53119009-49CEAA94-B026-431F-86E2-D2ECFE24DEBDQ53673152-B4C1B1E7-F708-46F3-B7D4-716208A9E808Q58139661-55204710-04A8-4EBC-8877-0912080B3CD5
P2860
Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combination regimen with stati ...... gy for cancer chemoprevention.
@en
Combination regimen with stati ...... gy for cancer chemoprevention.
@nl
type
label
Combination regimen with stati ...... gy for cancer chemoprevention.
@en
Combination regimen with stati ...... gy for cancer chemoprevention.
@nl
prefLabel
Combination regimen with stati ...... gy for cancer chemoprevention.
@en
Combination regimen with stati ...... gy for cancer chemoprevention.
@nl
P2860
P356
P1476
Combination regimen with stati ...... gy for cancer chemoprevention.
@en
P2093
Chung S Yang
P2860
P304
P356
10.1002/IJC.23718
P577
2008-09-01T00:00:00Z